FDA Week - 05/19/2017

Coalition Of Drug Makers, Insurers, PBMs Unveil Drug Pricing Platform

May 18, 2017
A coalition of insurers, drug makers and pharmacy benefit managers unveiled Wednesday (May 16) a slate of proposals they predict will lower drug prices, including pushing FDA to issue guidelines on preapproval communication between industry and payers, creating a priority review voucher for certain generics coupled with expedited FDA review of these drugs, exempting value-based arrangements from price reporting requirements, shielding value-based arrangements from anti-kickback and Stark laws, and encouraging data sharing. The coalition touts the proposals as the first...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to the Senate and its coming consideration of the American Health Care Act.